Perioperative Sicherheit der intraperitonealen Aerosolchemotherapie

[1]  N. Demartines,et al.  Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis , 2017, The British journal of surgery.

[2]  D. Nowak,et al.  Cisplatin and oxaliplatin surface contamination in intensive care units (ICUs) and hospital wards during attendance of HIPEC patients , 2016, International Archives of Occupational and Environmental Health.

[3]  M. Vaira,et al.  Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis , 2016, World Journal of Surgical Oncology.

[4]  W. Solass,et al.  [Occupational Health Aspects of Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC): Confirmation of Harmlessness]. , 2014, Zentralblatt fur Chirurgie.

[5]  W. Solass,et al.  Quality of life of patients with end-stage peritoneal metastasis treated with Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC). , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  Matthias Naegele,et al.  Umgang mit Zytostatika , 2014 .

[7]  P. Massucco,et al.  Contamination risk for operators performing semi-closed HIPEC procedure using cisplatin. , 2014, European Journal of Surgical Oncology.

[8]  Urs Giger-Pabst,et al.  Intraperitoneal Chemotherapy of Peritoneal Carcinomatosis Using Pressurized Aerosol as an Alternative to Liquid Solution: First Evidence for Efficacy , 2013, Annals of Surgical Oncology.

[9]  W. Solass,et al.  Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Occupational Health and Safety Aspects , 2013, Annals of Surgical Oncology.

[10]  J. Tuerk,et al.  Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies - the MEWIP project. , 2013, The Annals of occupational hygiene.

[11]  M. Jakubowski.  Biological monitoring versus air monitoring strategies in assessing environmental-occupational exposure. , 2012, Journal of environmental monitoring : JEM.

[12]  W. Solass,et al.  Description of a novel approach for intraperitoneal drug delivery and the related device , 2011, Surgical Endoscopy.

[13]  D. Nowak,et al.  Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC). , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[14]  E. Krieg,et al.  Evaluation of Antineoplastic Drug Exposure of Health Care Workers at Three University-Based US Cancer Centers , 2010, Journal of occupational and environmental medicine.

[15]  Nancy A Dreyer,et al.  Registries for robust evidence. , 2009, JAMA.

[16]  N. Demartines,et al.  Classification of Surgical Complications: A New Proposal With Evaluation in a Cohort of 6336 Patients and Results of a Survey , 2004, Annals of Surgery.

[17]  K. Kümmerer,et al.  Umgang mit Zytostatika: Eine Anleitung für die Praxis , 2004 .

[18]  P. Sugarbaker,et al.  Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. , 1996, Cancer treatment and research.